EUVIMEDEUVIMED entdecken
Scoping Review

Clinical profile and management of tetanus: A scoping review of evidence in the 21st century

NITIN GUPTA, PRAVEEN KUMAR TIRLANGI, SHREYA DAS ADHIKARI, MARTIN P. GROBUSCH, MANISH SONEJA

The National Medical Journal of India · 27.06.2026 · 1-6

DOI: 10.25259/nmji_382_2025 ↗

Kurz gefasst

Scoping Review in der Zeitschrift The National Medical Journal of India, online erschienen am 27.06.2026. Verfasst von NITIN GUPTA und 4 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tetanus, a vaccine-preventable but potentially fatal infection caused by Clostridium tetani, remains a public health concern, particularly in low-resource settings. This scoping review examines the clinical features, treatment strategies, and outcomes of tetanus in the 21st century.

Methods

A systematic search of PubMed and Embase (2000–2024) identified studies on tetanus epidemiology, clinical presentation, treatment, and outcomes. Data extraction and synthesis followed the Arksey and O’Malley framework and PRISMA for scoping reviews guidelines.

Results

The inclusion criteria were met by 34 studies. Tetanus primarily affects older adults in developed regions due to waning immunity, while younger populations in developing nations remain at risk due to insufficient immunization practices. Generalized tetanus was the most severe form, often requiring prolonged intensive care unit (ICU) admission and mechanical ventilation. Management includes toxin neutralization, antibiotics, benzodiazepines, magnesium sulphate, and supportive care. Human tetanus immunoglobulin (HTIG) is preferred for neutralizing unbound toxins; however, equine tetanus antitoxin (TAT) is an alternative in resource-limited settings. Intrathecal administration of HTIG has demonstrated greater efficacy compared to the intramuscular route. Siltartoxatug, a recombinant monoclonal antibody targeting tetanus toxin, has shown promise in providing faster and more durable seroprotection. Mortality ranged from 5.26% to 52.8%, with higher rates linked to short incubation periods, severe symptoms, and lack of ICU access.

Conclusion

Tetanus remains an important preventable global disease. Strengthening immunization programmes, maternal vaccination, and post-exposure prophylaxis is crucial in decreasing its incidence. Expanding ICU access, improving diagnostics, and optimising treatment strategies are key to reducing mortality and improving outcomes.

Zitieren

APA

GUPTA, N., TIRLANGI, P. K., ADHIKARI, S. D., GROBUSCH, M. P., & SONEJA, M. (2026). Clinical profile and management of tetanus: A scoping review of evidence in the 21st century. The National Medical Journal of India, 0, 1-6. https://doi.org/10.25259/nmji_382_2025

Vancouver

GUPTA N, TIRLANGI PK, ADHIKARI SD, GROBUSCH MP, SONEJA M. Clinical profile and management of tetanus: A scoping review of evidence in the 21st century. The National Medical Journal of India. 2026;0:1-6. doi:10.25259/nmji_382_2025

BibTeX
@article{GUPTA2026,
  author = {GUPTA, NITIN and TIRLANGI, PRAVEEN KUMAR and ADHIKARI, SHREYA DAS and GROBUSCH, MARTIN P. and SONEJA, MANISH},
  title = {Clinical profile and management of tetanus: A scoping review of evidence in the 21st century},
  journal = {The National Medical Journal of India},
  year = {2026},
  volume = {0},
  pages = {1--6},
  doi = {10.25259/nmji_382_2025}
}
Kostenlos starten →